Latest filing published 19 Apr 2024 for 亚虹医药.
Pan Ke: trading record in brief
All filings by Pan Ke on record concern 亚虹医药, in the capacity of board member. In total, 4 filings cover trades dated from 8 February 2024 to 19 April 2024.
Every open-market trade on record is a purchase: 4 purchases worth €157k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The median purchase comes to €20k. Across 4 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The latest filing, published on 19 April 2024, reports an open-market purchase of €116k in 亚虹医药. Most trades are made public on the day they happen. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Pan Ke
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 155,000 sharesA股XSHGSSE:173000007523398880Canonical exit: 18 Jul 2024 (T+90)
- 654 sharesA股XSHGSSE:173000007383578660Canonical exit: 9 Jun 2024 (T+90)
- 20,000 sharesA股XSHGSSE:173000007367374080Canonical exit: 3 Jun 2024 (T+90)
- 32,575 sharesA股XSHGSSE:173000007328106300Canonical exit: 8 May 2024 (T+90)
4 of 4 declarations